Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma

NCT00148317

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

NCT02098109

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

NCT00448357

Conditions: Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

NCT00006244

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

NCT01460420

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Medizinische Klinik and Poliklinik II, University Hospital Würzburg, Germany

S Giovanni Battista Hospital Torino, Italy

Azienda Ospedaliera Universitaria di Udine Udine, Italy

Hospital Clinic i Provincial, Barcelona, Spain

View Trial Details

Completed

Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

NCT00058240

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +25 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life

NCT00222105

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

NCT00342641

Conditions: Blood Protein Disorders, Blood-Borne Infections, Cardiovascular Diseases, +29 more
Locations: Houston Veterans AFfairs Medical Center Houston, Texas, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

NCT00691015

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +57 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions